Younghwa joined AstraZeneca in January 2012 as Senior Manager External Collaborations for the Asia and Emerging Markets Innovative Medicines (iMed) team. Younghwa also leads the Oncology iMed’s Science and Alliance team to identify, secure and manage opportunities in Asia that are aligned to AstraZeneca’s global oncology strategy as well as identifying and managing collaborative and licensing opportunities across other therapeutic areas in the region.

Prior to joining AstraZeneca, Younghwa held a number of R&D Business Development roles at Pfizer. She has a strong background in pharmaceutical research and development having also worked as a Research Scientist at MSD/Merck’s Immunology & Rheumatology laboratories in the United States before returning to Korea to work in the Green Cross Corporation’s R&D Strategy & Planning team.

Younghwa is an Immunologist by training having completed her Master’s Degree at Seoul National University, Korea and her PhD at Weill Cornell Medical School, USA. In her spare time she enjoys opera, fine dining, good wine and, most of all, spending time with friends.